ReviewCancers2021
Chimeric Antigen Receptor T-Cell Therapy: The Light of Day for Osteosarcoma.
Zili Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewCancers2021
Zili Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.